140 related articles for article (PubMed ID: 23762883)
1. Management of chronic obstructive pulmonary disease exacerbations: how well are we doing?
Vozoris NT
Can Respir J; 2013; 20(3):157-8. PubMed ID: 23762883
[No Abstract] [Full Text] [Related]
2. Variations in the management of acute exacerbations of chronic obstructive pulmonary disease.
Sandhu SK; Chu J; Yurkovich M; Harriman D; Taraboanta C; Fitzgerald JM
Can Respir J; 2013; 20(3):175-9. PubMed ID: 23762887
[TBL] [Abstract][Full Text] [Related]
3. Guideline adherence in management of stable chronic obstructive pulmonary disease.
Sharif R; Cuevas CR; Wang Y; Arora M; Sharma G
Respir Med; 2013 Jul; 107(7):1046-52. PubMed ID: 23639271
[TBL] [Abstract][Full Text] [Related]
4. Severity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospital.
Au LH; Chan HS
Hong Kong Med J; 2013 Dec; 19(6):498-503. PubMed ID: 23784531
[TBL] [Abstract][Full Text] [Related]
5. Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital.
Fanning M; McKean M; Seymour K; Pillans P; Scott I
Intern Med J; 2014 Sep; 44(9):903-10. PubMed ID: 24963727
[TBL] [Abstract][Full Text] [Related]
6. Improving adherence for management of acute exacerbation of chronic obstructive pulmonary disease.
Sonstein L; Clark C; Seidensticker S; Zeng L; Sharma G
Am J Med; 2014 Nov; 127(11):1097-1104. PubMed ID: 24927911
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Management of COPD Exacerbations: A Clinical Practice Guideline from the AAFP.
Stevermer JJ; Fisher L; Lin KW; Liu R; Goodenberger D; Schellhase K; Vaughan B; Bird MD
Am Fam Physician; 2021 Jul; 104(1):Online. PubMed ID: 34264593
[No Abstract] [Full Text] [Related]
8. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.
Franssen FM; Spruit MA; Wouters EF
Int J Chron Obstruct Pulmon Dis; 2011; 6():493-501. PubMed ID: 22069360
[TBL] [Abstract][Full Text] [Related]
9. Implementing a quality improvement initiative for the management of chronic obstructive pulmonary disease in rural Nepal.
Mehanni S; Jha D; Kumar A; Choudhury N; Dangal B; Deukmedjian G; Dhungana SK; Gauchan B; Gupta TK; Halliday S; Kalaunee SP; Mahar R; Poudel S; Raut A; Schwarz R; Singh DR; Thapa A; Thapa R; Wong L; Maru D; Schwarz D
BMJ Open Qual; 2019; 8(1):e000408. PubMed ID: 31259269
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the Global Initiative for Chronic Obstructive Lung Disease guidelines for management of COPD: a hospital-base study.
Masoompour SM; Mohammadi A; Mahdaviazad H
Clin Respir J; 2016 May; 10(3):298-302. PubMed ID: 25308344
[TBL] [Abstract][Full Text] [Related]
11. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
Brownridge DJ; Zaidi STR
J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
[TBL] [Abstract][Full Text] [Related]
12. Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital.
Sha J; Worsnop CJ; Leaver BA; Vagias C; Kinsella P; Rahman MA; McDonald CF
Intern Med J; 2020 Apr; 50(4):453-459. PubMed ID: 31157943
[TBL] [Abstract][Full Text] [Related]
13. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
Martinez FJ; Calverley PM; Goehring UM; Brose M; Fabbri LM; Rabe KF
Lancet; 2015 Mar; 385(9971):857-66. PubMed ID: 25684586
[TBL] [Abstract][Full Text] [Related]
14. [Medications for respiratory insufficiency and exacerbations].
Bischoff M
MMW Fortschr Med; 2015 Mar; 157(4):28-9. PubMed ID: 25743967
[No Abstract] [Full Text] [Related]
15. Order Set to Improve the Care of Patients Hospitalized for an Exacerbation of Chronic Obstructive Pulmonary Disease.
Brown KE; Johnson KJ; DeRonne BM; Parenti CM; Rice KL
Ann Am Thorac Soc; 2016 Jun; 13(6):811-5. PubMed ID: 27058777
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Schembri S; Williamson PA; Short PM; Singanayagam A; Akram A; Taylor J; Singanayagam A; Hill AT; Chalmers JD
BMJ; 2013 Mar; 346():f1235. PubMed ID: 23525864
[TBL] [Abstract][Full Text] [Related]
17. Is education at the crossroads?
Tomlins R
Prim Care Respir J; 2013 Mar; 22(1):6-8. PubMed ID: 23426417
[No Abstract] [Full Text] [Related]
18. U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations.
Myint PK; Lowe D; Stone RA; Buckingham RJ; Roberts CM
Respiration; 2011; 82(4):320-7. PubMed ID: 21597277
[TBL] [Abstract][Full Text] [Related]
19. Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines.
Ta M; George J
Intern Med J; 2011 Mar; 41(3):263-70. PubMed ID: 20002857
[TBL] [Abstract][Full Text] [Related]
20. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
